Mounjaro KwikPen 15 mg is the highest strength, offering maximum therapeutic effect for adults with type 2 diabetes who require stronger metabolic support.
| Composition | Tirzepatide |
| Manufacturer | Eli Lilly and Company |
| Packing | 1 Prefilled Pen of 2.4ml |
| Prescribed For | Type 2 Diabetes and Weight management |
| Expiry | December 2027 |
Mounjaro KwikPen 10 mg/0.6 ml is a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It works by increasing insulin release, reducing appetite, and slowing digestion to help maintain healthy glucose levels.
| Composition | Tirzepatide |
| Manufacturer | Eli Lilly and Company |
| Packing | 1 Prefilled Pen of 2.4ml |
| Prescribed For | Type 2 Diabetes and Weight management |
| Expiry | December 2027 |
